Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 534,317 | 697,966 | 684,636 | 565,221 | 288,678 |
| Marketable Securities | 94,032 | 153,995 | 187,213 | 192,209 | 233,120 |
| Receivables | 39,240 | 43,863 | 25,309 | 61,256 | 24,280 |
| Inventories | 15,211 | 16,030 | 8,581 | 5,565 | 4,359 |
| TOTAL | $704,070 | $937,710 | $927,759 | $841,655 | $568,312 |
| Non-Current Assets | |||||
| PPE Net | 31,848 | 32,991 | 34,129 | 35,199 | 36,745 |
| Investments And Advances | 751,702 | 578,168 | 677,873 | 598,470 | 128,475 |
| Other Non-Current Assets | 81,175 | 76,518 | 78,632 | 82,854 | 83,925 |
| TOTAL | $864,725 | $687,677 | $790,634 | $716,523 | $249,145 |
| Total Assets | $1,568,795 | $1,625,387 | $1,718,393 | $1,558,178 | $817,457 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,847 | 2,889 | 4,370 | 2,929 | 5,591 |
| Accrued Expenses | 107,173 | 86,479 | 105,938 | 89,116 | 84,062 |
| TOTAL | $125,397 | $112,437 | $130,802 | $110,108 | $105,086 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 7,912 | 14,876 | 12,559 | 10,391 | 8,017 |
| Other Non-Current Liabilities | 84,229 | 86,832 | 88,904 | 93,053 | 94,316 |
| TOTAL | $114,594 | $112,929 | $117,503 | $128,070 | $131,004 |
| Total Liabilities | $239,991 | $225,366 | $248,305 | $238,178 | $236,090 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,574 | 58,342 | 57,958 | 55,731 | 55,272 |
| Common Shares | 59 | 58 | 58 | 56 | 54 |
| Retained earnings | -839,514 | -731,070 | -631,356 | -545,688 | -1,179,666 |
| Other shareholders' equity | -5,835 | -5,097 | -5,214 | -1,940 | -1,120 |
| TOTAL | $1,328,804 | $1,400,021 | $1,470,088 | $1,320,000 | $581,367 |
| Total Liabilities And Equity | $1,568,795 | $1,625,387 | $1,718,393 | $1,558,178 | $817,457 |